Showing 1 - 16 results of 16 for search '"Pikeville, Kentucky"', query time: 0.30s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    Peripheral refraction and image blur in four meridians in emmetropes and myopes by Shen J, Spors F, Egan D, Liu C

    Published 2018-02-01
    “…Jie Shen,1 Frank Spors,1 Donald Egan,2 Chunming Liu3 1Western University of Health Sciences, College of Optometry, Pomona, CA, 2University of Pikeville Kentucky College of Optometry, Pikeville, KY, 3Pacific University College of Optometry, Forest Grove, OR, USA Introduction: The peripheral refractive error of the human eye has been hypothesized to be a major stimulus for the development of its central refractive error. …”
    Get full text
    Article
  9. 9
  10. 10

    Dry eye disease ranking among common reasons for seeking eye care in a large US claims database by Bradley JL, Özer Stillman I, Pivneva I, Guerin A, Evans AM, Dana R

    Published 2019-02-01
    “…John L Bradley,1,2 Ipek Özer Stillman,3 Irina Pivneva,4 Annie Guerin,4 Amber M Evans,5 Reza Dana6 1Naval Medical Research Unit Dayton, Vision Science Lab, Wright Patterson AFB, OH, USA; 2University of Pikeville, Kentucky College of Optometry, Pikeville, KY, USA; 3Takeda, Lexington, MA, USA; 4Analysis Group, Inc, Montreal, QC, Canada; 5Health ResearchTx LLC, Trevose, PA, USA; 6Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, MA, USA Objectives: Dry eye disease (DED) is a complex multifactorial condition of the ocular surface characterized by symptoms of ocular discomfort, irritation, and visual disturbance. …”
    Get full text
    Article
  11. 11

    Real-World Treatment Patterns Of Cyclosporine Ophthalmic Emulsion And Lifitegrast Ophthalmic Solution Among Patients With Dry Eye by White DE, Zhao Y, Ogundele A, Fulcher N, Acs A, Moore-Schiltz L, Karpecki PM

    Published 2019-11-01
    “…Darrell E White,1 Yang Zhao,2 Abayomi Ogundele,2 Nicole Fulcher,3 Annabel Acs,3 Laura Moore-Schiltz,3 Paul M Karpecki4 1Department of Ophthalmology, SkyVision Centers, Westlake, OH 44145, USA; 2Health Economics and Outcomes Research, Sun Pharmaceutical Industries, Princeton, NJ 08540, USA; 3Outcomes Research, IBM Watson Health, Cambridge, MA 02142, USA; 4Corneal Services and Advanced OSD Clinic, University of Pikeville Kentucky College of Optometry, Pikeville, KY 41501, USACorrespondence: Yang ZhaoHealth Economics and Outcomes Research, Sun Pharmaceutical Industries, Inc., 2 Independence Way, Princeton, NJ 08540, USATel +1 609 720 8132Email yang.zhao@sunpharma.comPurpose: To assess adherence, non-persistence, discontinuation, and switching of topical cyclosporine ophthalmic emulsion 0.05% (CYC) and lifitegrast ophthalmic solution 5% (LIF) use in the real world among patients with dry eye disease (DED).Design: Retrospective insurance claims study.Methods: Adult patients with DED and ≥1 prescription claim for CYC or LIF (first claim = index date) in the IBM® MarketScan® databases from July 2016 to February 2018 were identified. …”
    Get full text
    Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16